Literature DB >> 8445718

Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.

N R Manley1, M O'Connell, W Sun, N A Speck, N Hopkins.   

Abstract

The transcriptional enhancers of the Moloney and Friend murine leukemia viruses (MLV) are important determinants of viral pathogenicity. We used electrophoretic mobility shift and methylation interference assays to study nuclear factors which bind to a region of these enhancers whose sequence is identical between Moloney and Friend viruses and particularly highly conserved among 35 mammalian type C retroviruses whose enhancer sequences have been aligned (E. Golemis, N. A. Speck, and N. Hopkins, J. Virol. 64:534-542, 1990). Previous studies identified sites for the leukemia virus factor b (LVb) and core proteins in this region (N. A. Speck and D. Baltimore, Mol. Cell. Biol. 7:1101-1110, 1987) as well as a site, overlapping those for LVb and core, for a third factor (N. R. Manley, M. A. O'Connell, P. A. Sharp, and N. Hopkins, J. Virol. 63:4210-4223, 1989). Surprisingly, the latter factor appeared to also bind two sites identified in the Friend MLV enhancer, Friend virus factor a and b1 (FVa and FVb1) sites, although the sequence basis for the ability of the protein to bind these diverse sites was not apparent. Here we describe the further characterization of this binding activity, termed MCREF-1 (for mammalian type C retrovirus enhancer factor 1), and the identification of a consensus sequence for its binding, GGN8GG. We also identify a factor, abundant in mouse T-cell lines and designated LVt, which binds to two sites in the Moloney MLV enhancer, overlapping the previously identified LVb and LVc binding sites. These sites contain the consensus binding site for the Ets family of proteins. We speculate on how distinct arrays of these factors may influence the disease-inducing phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445718      PMCID: PMC240265     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

3.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Authors:  D Leprince; A Gegonne; J Coll; C de Taisne; A Schneeberger; C Lagrou; D Stehelin
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

4.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

5.  The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.

Authors:  D K Watson; M J McWilliams-Smith; M F Nunn; P H Duesberg; S J O'Brien; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Tripartite structure of the avian erythroblastosis virus E26 transforming gene.

Authors:  M F Nunn; P H Seeburg; C Moscovici; P H Duesberg
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

7.  Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.

Authors:  P A Chatis; C A Holland; J W Hartley; W P Rowe; N Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  The high leukemogenic potential of Gross passage A murine leukemia virus maps in the region of the genome corresponding to the long terminal repeat and to the 3' end of env.

Authors:  L DesGroseillers; R Villemur; P Jolicoeur
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

9.  Thymotropism of murine leukemia virus is conferred by its long terminal repeat.

Authors:  L DesGroseillers; E Rassart; P Jolicoeur
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

10.  A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system.

Authors:  M M Garner; A Revzin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

View more
  21 in total

1.  Molecular and phylogenetic analysis of SRS 19-6 murine leukemia virus.

Authors:  L M Bundy; H Fan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.

Authors:  Hideki Hanawa; Derek A Persons; Arthur W Nienhuis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity.

Authors:  N L DiFronzo; C A Holland
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.

Authors:  C Baum; K Itoh; J Meyer; C Laker; Y Ito; W Ostertag
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Cellular transcription factor ZASC1 regulates murine leukemia virus transcription.

Authors:  James W Bruce; Michael Hierl; John A T Young; Paul Ahlquist
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

6.  The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.

Authors:  J Pantginis; R M Beaty; L S Levy; J Lenz
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.

Authors:  A L Zaiman; A F Lewis; B E Crute; N A Speck; J Lenz
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression.

Authors:  C Barat; E Rassart
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.

Authors:  M J Martiney; L S Levy; J Lenz
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation.

Authors:  S Meyers; N Lenny; S W Hiebert
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.